Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manit Arya

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year ExperienceDeepika Reddy, Max Peters, Taimur T Shah, et al.
European Urology|March 22, 2024
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus RecommendationsAlexander Light, Nikhil Mayor, Emma Cullen, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
The Lancet. Oncology|March 3, 2022
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory studyAlistair D R Grey, Rebecca Scott, Bina Shah, et al.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year ExperienceDeepika Reddy, Max Peters, Taimur T Shah, et al.
European Urology|March 22, 2024
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus RecommendationsAlexander Light, Nikhil Mayor, Emma Cullen, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
The Lancet. Oncology|March 3, 2022
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory studyAlistair D R Grey, Rebecca Scott, Bina Shah, et al.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Pageof 13